Stock Events

Stock Events

Halozyme Therapeutics (HTI) Q1 2025 Earnings

18FebConfirmed

Q1 2025

1.16

1.19

1.23

1.26

Details

Expected EPS

1.158333

Actual EPS

1.26

Surprise EPS

0.1

Surprise Percent

+8.78%

Description

Halozyme Therapeutics (HTI) has reported earnings of 1.26 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.